Updated Jul 16, 2026 · Last SEC filing 2026-07-14
SOPHiA GENETICS SA (SOPH) has filed 47 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-14. 24 Form 144 notices of proposed sale were filed for SOPH stock. InsiderAlpha tracks every SOPH SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001840706 |
|---|
| Form 4 filings (90d) | 47 |
|---|---|
| Form 144 notices (90d) | 24 |
| Latest Form 4 filing | 2026-07-14 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Menu Philippe | Chief Medical Officer | S — Open-market sale [10b5-1] | 5.0K | $5.70 | $29K | SEC | |
| Xu Zhenyu | Chief Scientific Officer | S — Open-market sale [10b5-1] | 4.0K | $5.70 | $23K | SEC | |
| Camblong Jurgi | Executive Chairman | S — Open-market sale [10b5-1] | 8.5K | $5.62 | $48K | SEC | |
| Camblong Jurgi | Executive Chairman | S — Open-market sale | 17.7K | $5.28 | $93K | SEC | |
| Muken Ross | Chief Executive Officer | S — Open-market sale | 9.8K | $5.22 | $51K | SEC | |
| Puylaert Kevin | Chief Sales Officer | S — Open-market sale | 138 | $5.03 | $693 | SEC | |
| Puylaert Kevin | Chief Sales Officer | S — Open-market sale | 47 | $5.03 | $236 | SEC | |
| Camblong Jurgi | Executive Chairman | S — Open-market sale | 22.5K | $5.25 | $118K | SEC | |
| Puylaert Kevin | Chief Sales Officer | S — Open-market sale | 31 | $5.09 | $158 | SEC | |
| CARDOZA GEORGE | Chief Financial Officer | S — Open-market sale | 1.6K | $5.29 | $8K | SEC | |
| Menu Philippe | Chief Medical Officer | S — Open-market sale | 7.4K | $5.16 | $38K | SEC | |
| Xu Zhenyu | Chief Scientific Officer | S — Open-market sale | 7.4K | $5.17 | $38K | SEC | |
| Verma Abhimanyu | Chief Technology Officer | S — Open-market sale | 5.3K | $5.10 | $27K | SEC | |
| Valente Manuela | Chief People Officer | S — Open-market sale | 4.2K | $5.05 | $21K | SEC | |
| Camblong Jurgi | Executive Chairman | S — Open-market sale | 19.6K | $6.02 | $118K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for SOPHiA GENETICS SA (SOPH). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Camblong Jurgi | 21 | $1.50M |
| Menu Philippe | 9 | $197K |
| Xu Zhenyu | 6 | $105K |
| Puylaert Kevin | 5 | $1K |
| Muken Ross | 4 | $61K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in SOPH insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live SOPH dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.